File Download
  • No File Attached
 
 
Patent History
  • Application
    GB20070014337 2005-12-22
  • Granted
    GB 2437456 2009-11-11
 
Supplementary

Granted Patent: Diazene-bridged crown ether lithium compounds and methods for their use
  • Basic View
  • Metadata View
  • XML View
TitleDiazene-bridged crown ether lithium compounds and methods for their use
 
Granted PatentGB 2437456
 
Granted Date2009-11-11
 
Priority Date2005-12-22 PCT/CN2005002282
2004-12-22 US 11/638100P
 
InventorsPAUL MICHEL GEORGES VANHOUTTE
CHIMING CHE
KWOKFAI SO
HIUTUNG IONA SHAM
 
Issue Date2009
 
AbstractThis invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.
 
ReferencesJP 6116280 (A) 1994-04-26

US 5132436 (A) 1992-07-21

US 5705689 (A) 1998-01-06
 
DC FieldValue
dc.contributor.inventorPAUL MICHEL GEORGES VANHOUTTE
 
dc.contributor.inventorCHIMING CHE
 
dc.contributor.inventorKWOKFAI SO
 
dc.contributor.inventorHIUTUNG IONA SHAM
 
dc.date.accessioned2011-10-19T06:39:51Z
 
patents.date.application2005-12-22
 
dc.date.available2011-10-19T06:39:51Z
 
patents.date.granted2009-11-11
 
dc.date.issued2009
 
patents.date.priority2005-12-22 PCT/CN2005002282
 
patents.date.priority2004-12-22 US 11/638100P
 
dc.description.abstractThis invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.
 
patents.description.assigneeVANHOUTTE PAUL MICHEL GEORGES [CN]; CHE CHIMING [HK]; SO KWOKFAI [CN]; SHAM HIUTUNG IONA [CN]; UNIV HONG KONG [HK]
 
patents.description.ccGB
 
patents.description.countryUnited Kingdom
 
patents.description.kindB
 
patents.identifier.applicationGB20070014337
 
patents.identifier.grantedGB 2437456
 
patents.identifier.hkutechidChm-2004-00168
 
dc.identifier.urihttp://hdl.handle.net/10722/142243
 
patents.relation.familyCN 101115489 (A) 2008-01-30
 
patents.relation.familyDE 112005003183 (T5) 2007-11-08
 
patents.relation.familyJP 2008524268 (A) 2008-07-10
 
patents.relation.familyUS 2007298127 (A1) 2007-12-27
 
patents.relation.familyUS 7468434 (B2) 2008-12-23
 
patents.relation.familyWO 2006066511 (A1) 2006-06-29
 
dc.relation.referencesJP 6116280 (A) 1994-04-26
 
dc.relation.referencesUS 5132436 (A) 1992-07-21
 
dc.relation.referencesUS 5705689 (A) 1998-01-06
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
 
dc.titleDiazene-bridged crown ether lithium compounds and methods for their use
 
dc.typePatent
 
patents.typePatent_granted
 
<?xml encoding="utf-8" version="1.0"?>
<item><date.accessioned>2011-10-19T06:39:51Z</date.accessioned>
<date.available>2011-10-19T06:39:51Z</date.available>
<date.issued>2009</date.issued>
<identifier.uri>http://hdl.handle.net/10722/142243</identifier.uri>
<description.abstract>This invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.</description.abstract>
<rights>Creative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents</rights>
<title>Diazene-bridged crown ether lithium compounds and methods for their use</title>
<type>Patent</type>
<contributor.inventor>PAUL MICHEL GEORGES VANHOUTTE</contributor.inventor>
<contributor.inventor>CHIMING CHE</contributor.inventor>
<contributor.inventor>KWOKFAI SO</contributor.inventor>
<contributor.inventor>HIUTUNG IONA SHAM</contributor.inventor>
<relation.references>JP 6116280 (A)  1994-04-26</relation.references>
<relation.references>US 5132436 (A)  1992-07-21</relation.references>
<relation.references>US 5705689 (A)  1998-01-06</relation.references>
<patents.identifier.application>GB20070014337</patents.identifier.application>
<patents.identifier.granted>GB 2437456</patents.identifier.granted>
<patents.description.assignee>VANHOUTTE PAUL MICHEL GEORGES [CN]; CHE CHIMING [HK]; SO KWOKFAI [CN]; SHAM HIUTUNG IONA [CN]; UNIV HONG KONG [HK]</patents.description.assignee>
<patents.description.country>United Kingdom</patents.description.country>
<patents.date.granted>2009-11-11</patents.date.granted>
<patents.identifier.hkutechid>Chm-2004-00168</patents.identifier.hkutechid>
<patents.date.application>2005-12-22</patents.date.application>
<patents.date.priority>2005-12-22 PCT/CN2005002282</patents.date.priority>
<patents.date.priority>2004-12-22 US 11/638100P</patents.date.priority>
<patents.description.cc>GB</patents.description.cc>
<patents.relation.family>CN 101115489 (A)  2008-01-30</patents.relation.family>
<patents.relation.family>DE 112005003183 (T5)  2007-11-08</patents.relation.family>
<patents.relation.family>JP 2008524268 (A)  2008-07-10</patents.relation.family>
<patents.relation.family>US 2007298127 (A1)  2007-12-27</patents.relation.family>
<patents.relation.family>US 7468434 (B2)  2008-12-23</patents.relation.family>
<patents.relation.family>WO 2006066511 (A1)  2006-06-29</patents.relation.family>
<patents.description.kind>B</patents.description.kind>
<patents.type>Patent_granted</patents.type>
</item>